Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma

被引:0
|
作者
Kang, YK
Kim, WH
Lee, HW
Lee, HK
Kim, YI
机构
[1] Seoul Natl Univ, Coll Med, Dept Pathol, Chongno Gu, Seoul 110744, South Korea
[2] Inje Univ, Seoul Paik Hosp, Dept Pathol, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Ctr Canc Res, Seoul 110744, South Korea
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Intrahepatic cholangiocarcinoma (ICC) is the second most common malignant tumor in liver; however, the carcinogenic mechanism of ICC is poorly understood. To analyze the molecular carcinogenesis of ICC, we examined the alterations of the p53, APC, and K-ras genes in 40 surgically resected ICC cases. The single-strand conformation polymorphism/sequencing revealed a p53 mutation in 12 cases (30%). An immunohistochemical overexpression of the p53 gene was detected in 10 cases (25%). The PCR/RFLP showed loss of heterozygosity of APC in 4 of 17 informative cases (23.5%). And the PCR/RFLP assay or K-ras codon 12 revealed the mutation in nine cases (22.5%). Twenty-one cases (52.5%) showed an alteration of at least one of the examined genes, and six (15%) carried an abnomality in more than two genes. The analysis of the clinicopathologic findings disclosed a significant relationship between the genetic alteration and gross type of the tumor: the p53 mutation was prominent in the ICC of mass-forming type, and K-ras mutation occurred more frequently in the ICC of periductal extension type (p < 0.05). These data suggest that each of the examined genes is involved in the development of ICC and that the p53 and K-ras mutation may play a role in the tumor growth pattern.
引用
收藏
页码:477 / 483
页数:7
相关论文
共 50 条
  • [1] Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma
    Isa, T
    Tomita, S
    Nakachi, A
    Miyazato, H
    Shimoji, H
    Kusano, T
    Muto, Y
    Furukawa, M
    [J]. HEPATO-GASTROENTEROLOGY, 2002, 49 (45) : 604 - 608
  • [2] P53 AND K-RAS GENE-MUTATIONS IN CHOLANGIOCARCINOMA
    NAKEEB, A
    SLEBOS, RJC
    HRUBAN, RH
    DOOLEY, WC
    OFFERHAUS, GJA
    PITT, HA
    [J]. HEPATOLOGY, 1995, 22 (04) : 156 - 156
  • [3] The prognostic significance of K-ras, p53, and APC in colorectal adenocarcinoma
    Conlin, A
    Smith, G
    Carey, FA
    Wolf, CR
    Steele, RJC
    [J]. GUT, 2004, 53 : A21 - A21
  • [4] P53 EXPRESSION AND K-RAS MUTATION IN COLORECTAL ADENOMAS
    SCOTT, N
    BELL, SM
    SAGAR, P
    BLAIR, GE
    DIXON, MF
    QUIRKE, P
    [J]. GUT, 1993, 34 (05) : 621 - 624
  • [5] The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma
    Conlin, A
    Smith, G
    Carey, FA
    Wolf, CR
    Steele, RJC
    [J]. GUT, 2005, 54 (09) : 1283 - 1286
  • [6] Aberrations of the K-ras, p53, and APC genes in extrahepatic bile duct cancer
    Suto, T
    Habano, W
    Sugai, T
    Uesugi, N
    Funato, O
    Kanno, S
    Saito, K
    Nakamura, SI
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2000, 73 (03) : 158 - 163
  • [7] MUTATION STATUS OF EGFR, K-RAS AND P53 IN SORTED ADENOCARCINOMA CELLS
    Kaneda, Hiroyuki
    Nakano, Takahito
    Saito, Tomohito
    Minami, Kenichiro
    Konobu, Toshifumi
    Saito, Yukihito
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S950 - S950
  • [8] Mutation of K-ras and p53 in pulmonary adenocarcinoma - Histologic correlations.
    Yadrandji, S
    Visscher, DW
    Madan, SK
    Valdivieso, M
    Sarkar, FH
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 961 - 961
  • [9] K-ras mutation and loss of heterozygosity of chromosome 17p and survival in colorectal cancer
    Fung, C
    Bragg, T
    Newland, R
    Dent, O
    Nicholson, G
    Bokey, L
    Chapuis, P
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1997, 67 (05): : 239 - 244
  • [10] Mutations of APC, K-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas
    Leslie, A
    Pratt, NR
    Gillespie, K
    Sales, M
    Kernohan, NM
    Smith, G
    Wolf, CR
    Carey, FA
    Steele, RJC
    [J]. CANCER RESEARCH, 2003, 63 (15) : 4656 - 4661